Browsing Category

Components

Nvidia & Samsung – GTC Day 2

Samsung’s fate is bound up with Nvidia GTC Update: Nvidia Dynamo – the most critical launch of 2025.  GTC 2025 is in full swing and as more details emerge about...

Nvidia GTC 2025 – Spread Betting

Nvidia is spreading its bets wide and early.   Another confident keynote from Jensen Huang where technical slip-ups were part of the show and where the best was saved for...

Intel – Anywhere to Go?

Mr Tan’s options already seem very limited.  The recruitment of Lip-Bu Tan as the new CEO of Intel should come with an expectation of a strategic shift that increases the...

Nvidia & Meta – Safe for Now

Nvidia is not close to danger yet.   The worst-kept secret in tech is that Nvidia’s customers are all trying to reduce their dependence on Nvidia by building their own...

Nvidia FQ4 25 – On the Nose

Not too little, not too much, just right. Nvidia reported results that confirmed that the AI spending spree remains on track, but this growth is now captured in the estimates...

iPhone 16e – Pugilistic Intent

New modem needs to succeed to re-open hostilities. Apple has finally launched a phone that uses its own in-house 5G modem, but the real test of success will be whether...

Arm – Balancing Act

Arm will need a major charm offensive. It turns out that Arm may be looking to make its own chips after all in a move that needs to be carefully...

Qualcomm vs. Arm – Short but Sharp pt. III

Qualcomm looks to be off the hook until 2033. As details emerge following the end of the trial in December, documents confirm that Qualcomm does have a license for V9...

Qualcomm vs. Arm – Short but Sharp pt. II

RFM returns for one more update before CES 2025 Qualcomm wins, but not entirely. The jury has delivered Qualcomm a significant win in its battle with Arm and while Arm...

Qualcomm vs. Arm – Short but Sharp

I still think the dispute will settle. The dispute has gone to trial with both sides scoring points, but the outcome remains pretty uncertain where the outcome of this trial...